{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:15:43Z","timestamp":1794330943656,"version":"4.9.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["084344"],"award-info":[{"award-number":["084344"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015550","name":"Ministry of Health, Uganda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017230","name":"Uganda National Council for Science and Technology","doi-asserted-by":"publisher","award":["HS452ES"],"award-info":[{"award-number":["HS452ES"]}],"id":[{"id":"10.13039\/501100017230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004421","name":"World Bank Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004421","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jctube.2021.100221","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T01:59:46Z","timestamp":1611712786000},"page":"100221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Treatment outcomes of drug resistant tuberculosis patients with multiple poor prognostic indicators in Uganda: A countrywide 5-year retrospective study"],"prefix":"10.1016","volume":"23","author":[{"given":"Joseph Baruch","family":"Baluku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Nakazibwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Naloka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1727-9813","authenticated-orcid":false,"given":"Martin","family":"Nabwana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Mwanja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Mulwana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Sempiira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Nassozi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Febronius","family":"Babirye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Namugenyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Ntambi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Namiiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4515-8517","authenticated-orcid":false,"given":"Felix","family":"Bongomin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Katuramu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Andia-Biraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Worodria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jctube.2021.100221_b0005","unstructured":"World Health Organization, Global tuberculosis report 2019. In: Global tuberculosis report 2019; 2019."},{"issue":"1","key":"10.1016\/j.jctube.2021.100221_b0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40249-016-0214-x","article-title":"Treatment outcomes for multidrug-resistant tuberculosis under DOTS-Plus: a systematic review and meta-analysis of published studies","volume":"6","author":"Kibret","year":"2017","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"10.1016\/j.jctube.2021.100221_b0015","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2471\/BLT.13.122028","article-title":"Principles for designing future regimens for multidrug-resistant tuberculosis","volume":"92","author":"Brigden","year":"2014","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.jctube.2021.100221_b0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-23344-z","article-title":"Comorbidities and treatment outcomes in multidrug resistant tuberculosis: a systematic review and meta-analysis","volume":"8","author":"Samuels","year":"2018","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.jctube.2021.100221_b0025","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1136\/thoraxjnl-2015-207374","article-title":"Achieving high treatment success for multidrug-resistant TB in Africa: initiation and scale-up of MDR TB care in Ethiopia\u2014an observational cohort study","volume":"70","author":"Meressa","year":"2015","journal-title":"Thorax"},{"issue":"12","key":"10.1016\/j.jctube.2021.100221_b0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082943","article-title":"Risk factors for poor treatment outcomes in patients with MDR-TB and XDR-TB in China: retrospective multi-center investigation","volume":"8","author":"Tang","year":"2013","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.jctube.2021.100221_b0035","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1183\/09031936.00197912","article-title":"Predictors of treatment outcome in multidrug-resistant tuberculosis in Portugal","volume":"42","author":"Oliveira","year":"2013","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.jctube.2021.100221_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006914","article-title":"Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis","volume":"4","author":"Johnston","year":"2009","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.jctube.2021.100221_b0045","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cmi.2017.07.008","article-title":"Treatment outcomes of multidrug-resistant tuberculosis patients in Zhejiang, China, 2009\u20132013","volume":"24","author":"Zhang","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.jctube.2021.100221_b0050","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/cid\/civ910","article-title":"Multidrug-resistant tuberculosis treatment outcomes in relation to treatment and initial versus acquired second-line drug resistance","volume":"62","author":"Cegielski","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jctube.2021.100221_b0055","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1186\/s12889-019-7838-2","article-title":"Time to poor treatment outcome and its predictors among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara region, Ethiopia: retrospective cohort study","volume":"19","author":"Ketema","year":"2019","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jctube.2021.100221_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/3569018","article-title":"Predictors of treatment outcomes among multidrug resistant tuberculosis patients in Tanzania","volume":"2019","author":"Leveri","year":"2019","journal-title":"Tubercul. Res. Treatm."},{"issue":"1","key":"10.1016\/j.jctube.2021.100221_b0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5588\/pha.17.0098","article-title":"Did diabetes mellitus affect treatment outcome in drug-resistant tuberculosis patients in Pakistan from 2010 to 2014?","volume":"8","author":"Latif","year":"2018","journal-title":"Public Health Action"},{"issue":"6","key":"10.1016\/j.jctube.2021.100221_b0070","doi-asserted-by":"crossref","first-page":"1602363","DOI":"10.1183\/13993003.02363-2016","article-title":"Treatment outcomes of MDR-TB and HIV co-infection in Europe","volume":"49","author":"Magis-Escurra","year":"2017","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.jctube.2021.100221_b0075","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1513\/AnnalsATS.201312-447OC","article-title":"Does alcohol consumption during multidrug-resistant tuberculosis treatment affect outcome?","volume":"11","author":"Duraisamy","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jctube.2021.100221_b0080","doi-asserted-by":"crossref","DOI":"10.5152\/ttd.2013.20","article-title":"The effect of smoking on treatment outcome of multidrug-resistant tuberculosis","author":"Pazarli","year":"2013","journal-title":"Tur Toraks Der"},{"key":"10.1016\/j.jctube.2021.100221_b0085","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.12659\/MSM.904682","article-title":"Adverse events associated with treatment of multidrug-resistant tuberculosis in china: an ambispective cohort study","volume":"23","author":"Zhang","year":"2017","journal-title":"Med Sci Monit"},{"issue":"1","key":"10.1016\/j.jctube.2021.100221_b0090","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s12879-019-3919-1","article-title":"Incidence and predictors of major adverse drug events among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara regional state public hospitals; Ethiopia: a retrospective cohort study","volume":"19","author":"Merid","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.jctube.2021.100221_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227100","article-title":"Development of a risk score for prediction of poor treatment outcomes among patients with multidrug-resistant tuberculosis","volume":"15","author":"Alene","year":"2020","journal-title":"PLOS ONE"},{"issue":"suppl 60","key":"10.1016\/j.jctube.2021.100221_b0100","first-page":"PA1912","article-title":"Multidrug-resistant tuberculosis in pregnant women: treatment and birth outcomes","volume":"48","author":"Dudnyk","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jctube.2021.100221_b0105","series-title":"Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity","author":"World Health Organization","year":"2011"},{"issue":"12","key":"10.1016\/j.jctube.2021.100221_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003919","article-title":"Reference intervals in healthy adult Ugandan blood donors and their impact on conducting international vaccine trials","volume":"3","author":"Eller","year":"2008","journal-title":"PLOS ONE"},{"key":"10.1016\/j.jctube.2021.100221_b0115","unstructured":"Ministry of Health, Uganda national guidelines for the programmatic management of drug resistant tuberculosis; 2011."},{"key":"10.1016\/j.jctube.2021.100221_b0120","unstructured":"Ministry of Health, National HIV Testing Services Policy and Implementation Guidelines. Ministry of Health of Uganda; 2016."},{"key":"10.1016\/j.jctube.2021.100221_b0125","series-title":"Definitions and reporting framework for tuberculosis\u20132013 revision","author":"World Health Organization","year":"2013"},{"issue":"2","key":"10.1016\/j.jctube.2021.100221_b0130","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ajic.2016.07.026","article-title":"Risk factors for high death and loss-to-follow-up rates among patients with multidrug-resistant tuberculosis at a programmatic management unit","volume":"45","author":"Javaid","year":"2017","journal-title":"Am J Infect Control"},{"issue":"6","key":"10.1016\/j.jctube.2021.100221_b0135","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/trstmh\/trz126","volume":"114","author":"Adejumo","year":"2020","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.jctube.2021.100221_b0140","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.21037\/jtd.2018.05.11","article-title":"Management of drug-resistant tuberculosis in special sub-populations including those with HIV co-infection, pregnancy, diabetes, organ-specific dysfunction, and in the critically ill","volume":"10","author":"Esmail","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jctube.2021.100221_b0145","series-title":"Policy implementation package for new TB drug introduction","author":"World Health Organization","year":"2014"},{"issue":"3","key":"10.1016\/j.jctube.2021.100221_b0150","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.amjms.2019.05.016","article-title":"Relations of anemia with the all-cause mortality and cardiovascular mortality in general population: a meta-analysis","volume":"358","author":"Liu","year":"2019","journal-title":"Am J Med Sci"},{"issue":"4","key":"10.1016\/j.jctube.2021.100221_b0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195985","article-title":"Anemia in tuberculosis cases and household controls from Tanzania: contribution of disease, coinfections, and the role of hepcidin","volume":"13","author":"Hella","year":"2018","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.jctube.2021.100221_b0160","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3945\/jn.111.144287","article-title":"Iron deficiency and anemia predict mortality in patients with tuberculosis","volume":"142","author":"Isanaka","year":"2012","journal-title":"J. Nutr."},{"issue":"3","key":"10.1016\/j.jctube.2021.100221_b0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091229","article-title":"Anemia at the initiation of tuberculosis therapy is associated with delayed sputum conversion among pulmonary tuberculosis patients in Dar-es-Salaam, Tanzania","volume":"9","author":"Nagu","year":"2014","journal-title":"PLOS ONE"},{"issue":"3","key":"10.1016\/j.jctube.2021.100221_b0170","article-title":"Exploring the iron metabolism in multidrug resistant tuberculosis (MDR-TB) patients in treatment","volume":"11","author":"Bahi","year":"2017","journal-title":"Int J Biol Chem Sci"},{"issue":"5","key":"10.1016\/j.jctube.2021.100221_b0175","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/cid\/ciu945","article-title":"Complex anemia in tuberculosis: the need to consider causes and timing when designing interventions","volume":"60","author":"Minchella","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jctube.2021.100221_b0180","first-page":"2019","article-title":"Linezolid for drug-resistant pulmonary tuberculosis","volume":"3","author":"Singh","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"9456","key":"10.1016\/j.jctube.2021.100221_b0185","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(05)17786-1","article-title":"Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study","volume":"365","author":"Leimane","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jctube.2021.100221_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058664","article-title":"Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality","volume":"8","author":"Mitnick","year":"2013","journal-title":"PLOS ONE"},{"issue":"Suppl 58","key":"10.1016\/j.jctube.2021.100221_b0195","article-title":"Comorbidities and MDR-TB treatment outcomes in Georgia-2009-11 cohort","volume":"44","author":"Kikvidze","year":"2014","journal-title":"Eur Respir J"},{"issue":"10248","key":"10.1016\/j.jctube.2021.100221_b0200","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0140-6736(20)31316-7","article-title":"Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis","volume":"396","author":"Bisson","year":"2020","journal-title":"Lancet"}],"container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579421000103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579421000103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:37:13Z","timestamp":1762501033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405579421000103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":40,"alternative-id":["S2405579421000103"],"URL":"https:\/\/doi.org\/10.1016\/j.jctube.2021.100221","relation":{},"ISSN":["2405-5794"],"issn-type":[{"value":"2405-5794","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment outcomes of drug resistant tuberculosis patients with multiple poor prognostic indicators in Uganda: A countrywide 5-year retrospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jctube.2021.100221","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100221"}}